Antidepressant Drugs Market Growth, Size, Share and Forecast 2019-2025

Posted July 24, 2020 by globalomr

Global Antidepressant Drugs Market Size, Share & Trends Analysis Report by Depressive Disorder, By Drug Class, and Forecast 2019-2025

The global antidepressant drug market is expected to grow at a significant CAGR during the forecast period. Antidepressants are used for the treatment of all age group patients suffering from clinical and anxiety depression and are further used for regulating mood. As per the Centers for Disease Control and Prevention (CDC), during the period, 2011–2014, 12.7% of people aged 12 and overtook antidepressant medication. This, in turn, reflects the increasing demand for antidepressant drugs in the market.

Based on the drug class, the antidepressant drugs market is segmented into selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), atypical antidepressants, monoamine oxidase inhibitors (MAOIs), and other medications. SSRIs segment held a significant share in the global antidepressant drug market.

A full report of Global Antidepressant Drugs Market is available at:

SSRIs aim to relieve symptoms that work by blocking the reuptake, or reabsorption, of serotonin by some brain nerve cells. It increases the serotonin level in the brain, which improves mood. SSRIs drugs include sertraline, escitalopram, citalopram, fluoxetine, and paroxetine, usually produced at least side effects, as compared to tricyclic antidepressants. The common side effects of these drugs comprise sexual dysfunction, sleepiness or insomnia, and weight gain. These types of drugs are considered a potential treatment for all kinds of anxiety disorders; however, the treatment of OCD normally requires higher doses.

To learn more about this report request a free sample copy @

SNRIs class include duloxetine and venlafaxine, which is known for its dual mechanism of action, such as enhancing the levels of the norepinephrine and neurotransmitters serotonin by constraining their reabsorption into brain cells. Like other medications, its possible side effects include a minor increase in blood pressure, headache, stomach upset, insomnia, sexual dysfunction, and weight gain. Such medications are considered as potential as SSRIs, and therefore, it is also considered as a first-line treatment to treat anxiety disorders. However, it is not preferred for OCD, where SSRIs are usually chosen as a first-line treatment.

However, antidepressants may trigger hypomania or mania in some people. If the patient stops taking the antidepressant, it can worsen bipolar symptoms. In this case, the patient may be given a new diagnosis and different medication. Several other side-effects that are associated with antidepressants include neuroleptic malignant syndrome, suicidal feelings, SIADH (Syndrome of Inappropriate Antidiuretic Hormone Secretion), and serotonin syndrome. Due to these concerns, major pharmaceutical companies, including GSK, AstraZeneca, Pfizer, Merck, and Sanofi slowed researches on new antidepressants altogether.
This, in turn, results in slowing down the adoption rate and the overall antidepressant drug market.

Global Antidepressant Drugs Market – Segmentation

By Depressive Disorder

• Major Depressive Disorder (MDD)
• Obsessive-compulsive Disorder (OCD)
• Generalized Anxiety Disorder (GAD)
• Panic Disorder (PD)
• Other Depressive Disorders

By Drug Class

• Selective Serotonin Reuptake Inhibitors (SSRIs)
• Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
• Atypical Antidepressants
• Monoamine Oxidase Inhibitors (MAOIs)
• Other Medications

For more customized data, request for report customization @

Global Antidepressant Drugs Market– Segment by Region

North America

• United States
• Canada


• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe


• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Alkermes Plc
• Allergan PLC
• Breckenridge Pharmaceutical, Inc.
• AstraZeneca Plc
• Bristol Myers Squibb Co.
• Camber Pharmaceutical Inc.
• Eli Lilly & Co.
• GlaxoSmithKline Plc
• H. Lundbeck A/S
• Intellipharmaceutics International Inc.
• Johnson & Johnson Services Inc.
• Merck & Co., Inc.
• Mylan N.V.
• Novartis International AG
• Pfizer Inc.
• Sanofi S.A.
• Sun Pharmaceuticals Ltd.
• Takeda Pharmaceutical Co.
• Teva Pharmaceutical Industries Ltd.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Arti Sharma
Phone +91 7803040404
Business Address 305-308, Commerce House, Janjeerwala Square, Indore, Madhya Pradesh 452001
Country India
Categories Business , Health , Medical
Tags antidepressant , disorder , drug , healthcare , pharmaceuticals
Last Updated July 24, 2020